Abstract

As the most widely used mammalian cell line, Chinese hamster ovary (CHO) cells can express various recombinant proteins with a post translational modification pattern similar to that of the proteins from human cells. During industrial production, cells need large amounts of ATP to support growth and protein expression, and since glycometabolism is the main source of ATP for cells, protein production partly depends on the efficiency of glycometabolism. And efficient glycometabolism allows less glucose uptake by cells, reducing production costs, and providing a better mammalian production platform for recombinant protein expression. In the present study, a series of progresses on the comprehensive optimization in CHO cells by glycometabolism strategy were reviewed, including carbohydrate intake, pyruvate metabolism and mitochondrial metabolism. We analyzed the effects of gene regulation in the upstream and downstream of the glucose metabolism pathway on cell’s growth and protein expression. And we also pointed out the latest metabolic studies that are potentially applicable on CHO cells. In the end, we elaborated the application of metabolic models in the study of CHO cell metabolism.

Highlights

  • In recent years, the proportion of biological drugs in the global pharmaceutical market has been expanding

  • It has been demonstrated that Chinese hamster ovary (CHO) cells overexpressing yeast pyruvate carboxylase (PYC2) showed an approximately fourfold reduction in lactate accumulation and a 70% increase in monoclonal antibody production compared to controls (Gupta et al, 2017)

  • In the past few years, we have witnessed the progress of the CHO cells in many aspects

Read more

Summary

Introduction

The proportion of biological drugs in the global pharmaceutical market has been expanding. CHO cells overexpressing galactose kinase (GALK1) were cultured in a medium containing galactose, which increased their specific growth rate by 39% and maintained their growth with galactose as the main carbon source.

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.